Block Drug Corporation has approval to use Atridox™ (10.0% doxycycline hyclate) in the ATRIGEL® delivery system for the treatment of periodontal disease. Atridox™ offers a new treatment option that is both effective and comfortable for the millions of Americans plagued with infected, inflamed gums associated with periodontal disease.
Block Drug Corporation has approval to use Atridox™ (10.0% doxycycline hyclate) in the ATRIGEL® delivery system for the treatment of periodontal disease. Atridox™ offers a new treatment option that is both effective and comfortable for the millions of Americans plagued with infected, inflamed gums associated with periodontal disease.
Atridox™ combines the antibiotic doxycycline with a unique gel that the dentist applies to periodontal pockets to fight the bacteria that cause this chronic infection in adults. Atridox™ continuously releases the antibiotic over seven days to safely fight the periodontal infection.
For more details, contact Block Drug Corporation at (800) 365-6500.
Whether you recently decided to make the leap or are still thinking it over, moving from server-based to cloud-based practice management software requires careful thought and ...
You've likely heard of “cloud-based” practice management software, but understanding it is another matter. Simply put, it involves accessing data via the internet, offering flexibility...
Discussing dental costs can be uncomfortable, but patient-led financing lets patients privately explore options that fit their budget, making it easier to accept necessary care...
Is your practice easy for patients to work with, or is there room for improvement? A recent report highlights that convenience, especially in digital support and access, often...
